Efficacy and safety of long-acting injectable paliperidone palmitate 1-month and 3-month formulations in the maintenance treatment of schizophrenia: a single-arm, open-label, interventional study in Rwandan healthcare settings. - Bizoza R; Mehawej J; Musoni-Rwililiza E; Alphs L; Turkoz I; Sun L; Killion L; Decotelli-Mendes C; Knight RK (BMJ open, 2026)